Grants and Contributions

• The CIHR Institute of Nutrition, Metabolism and Diabetes (INMD) will provide funding for an application determined to be relevant to the broad INMD mandate as described below:
o CIHR-INMD supports research to enhance health in relation to diet, digestion, excretion, and metabolism; and to address causes, prevention, screening, diagnosis, treatment, support systems, and palliation for a wide range of conditions and problems associated with hormone, digestive system, kidney, and liver.
• These grants afford principal investigators an opportunity to resubmit their research proposal without the loss of momentum, staff or trainees.

To provide recognition and funding to academic researchers; to provide a reliable supply of highly skilled and qualified researchers.

This funding opportunity is expected to:
•Catalyze patient-oriented research aligned with the SPOR Patient Engagement Framework and SPOR Capacity Development Framework by:
¿Developing partnerships amongst patients and patient communities, researchers, health care professionals and health system decision-makers or policy-makers;
¿Mobilizing the above partnerships to develop and conduct a patient-oriented research project or projects; and,
¿Informing future applications for more comprehensive patient-oriented research grants.

Scale and Spread of Successful Existing CBPHC and eHealth Innovations grant is expected to:
• Support the adoption of successful CBPHC and eHealth innovations to new sites, new settings, or new populations.
• Support knowledge translation to inform practice, clinical care, policy, and/or decision making.
• Build and support partnerships between researchers and health system decision makers.

The “Catalyst Grant: Addressing Musculoskeletal Conditions and Arthritis in Canadians” is expected to:
•Support original, high quality projects that have the potential to generate innovative research, research tools, techniques, devices, inventions, or methods that will translate into a clinical or health services improvement for Canadians within 5-7 years;
•Facilitate team formation and build patient-oriented research capacity by encouraging partnerships amongst patients, patient communities, patient organizations and health charities, researchers, health care professionals and health system decision makers or policy makers;
•Generate preliminary observations, data or knowledge to stimulate research in areas where there is a substantial burden of disease in musculoskeletal conditions and arthritis in Canada, as identified by the respective communities.

The “Catalyst Grant: Addressing Musculoskeletal Conditions and Arthritis in Canadians” is expected to:

• Support original, high quality projects that have the potential to generate innovative research, research tools, techniques, devices, inventions, or methods that will translate into a clinical or health services improvement for Canadians within 5-7 years;
• Facilitate team formation and build patient-oriented research capacity by encouraging partnerships amongst patients, patient communities, patient organizations and health charities, researchers, health care professionals and health system decision makers or policy makers;
• Generate preliminary observations, data or knowledge to stimulate research in areas where there is a substantial burden of disease in musculoskeletal conditions and arthritis in Canada, as identified by the respective communities.

Scale and Spread of Successful Existing CBPHC and eHealth Innovations grant is expected to:
• Support the adoption of successful CBPHC and eHealth innovations to new sites, new settings, or new populations.
• Support knowledge translation to inform practice, clinical care, policy, and/or decision making.
• Build and support partnerships between researchers and health system decision makers.

• The CIHR HIV/AIDS Research Initiative, which is responsible for the management and oversight of the research components of the Federal Initiative to Address HIV/AIDS in Canada, will provide funding for applications that have a primary focus on HIV/AIDS and/or other sexually-transmitted and blood-borne infections (STBBIs) across all CIHR Research Themes (i.e., biomedical research, clinical research, health services research and social, cultural, environmental and population health research).
• Research that focuses on key populations identified by the Federal Initiative to Address HIV/AIDS in Canada is highly encouraged.

This funding opportunity is expected to:

• Advance knowledge through the analysis of existing cohorts, data platforms and/or administrative datasets specific to one of the research areas above.

The Operating Grant: Methamphetamine and related psychostimulant use is expected to:

• Generate new knowledge around prevalence, incidence, and distribution of methamphetamine use in Canada
• Increase the uptake and application of synthesized knowledge in evidence-based decision-making, health care and/or health services policy and practice in this space
• Support partnerships between researchers and knowledge users to rapidly inform policies related to prevention, harm reduction, and treatment of methamphetamine use
• Address the pressing intervention-related evidence needs of knowledge users in this space
• Encourage implementation science approaches that consider sub-populations and/or the biological and social determinants of methamphetamine use